GÁL, Břetislav, Jan ROTTENBERG, Marta PAZOURKOVA, Jiří VANÍČEK and Ermis VOGAZIANOS. Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2018, vol. 162, No 3, p. 178-183. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2018.013.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle
Authors GÁL, Břetislav (203 Czech Republic, belonging to the institution), Jan ROTTENBERG (203 Czech Republic, guarantor, belonging to the institution), Marta PAZOURKOVA (203 Czech Republic), Jiří VANÍČEK (203 Czech Republic, belonging to the institution) and Ermis VOGAZIANOS (196 Cyprus).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2018, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30206 Otorhinolaryngology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.141
RIV identification code RIV/00216224:14110/18:00103841
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2018.013
UT WoS 000445913000003
Keywords (in Czech) CPA tumours, diagnosis
Keywords in English CPA tumours; diagnosis
Tags 14110119, 14110126, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 2/5/2019 13:56.
Abstract
The correct diagnosis of CPA tumours is a relatively common issue in both neurological and ENT practice, the omission of which can have serious consequences for the patient. Properly set clinical guidelines and diagnostic protocols are key aspects of good clinical practice. In the case of CPA tumours, two options are available: the first is diagnosis with the help of an ABR as the primary tool for determining the group of patients with a possible tumour; the second is an MRI scan of the posterior cranial fossa. With an appropriately set diagnostic protocol in place, and despite the 40% chance of failure of the ABR to detect tumours less than or equal to 1 cm, similar treatment results can be achieved with much higher cost efficacy in case of primary ABR testing.
PrintDisplayed: 20/7/2024 21:21